中国医药导报
中國醫藥導報
중국의약도보
CHINA MEDICAL HERALD
2014年
23期
140-143,147
,共5页
徐跃%陈乔彬%皇甫英%张静
徐躍%陳喬彬%皇甫英%張靜
서약%진교빈%황보영%장정
妊娠%妊娠期甲状腺功能减退症%妊娠结局%左旋甲状腺素
妊娠%妊娠期甲狀腺功能減退癥%妊娠結跼%左鏇甲狀腺素
임신%임신기갑상선공능감퇴증%임신결국%좌선갑상선소
Pregnancy%Hypothyroidism%Regnancy outcomes%L-T4
目的:分析妊娠合并临床甲状腺功能减退及亚临床甲状腺功能减退经激素替代治疗后妊娠结局。方法回顾分析2012年1月~2013年12月广东省深圳市南山区妇幼保健院产科92例临床甲状腺功能减退(OH组)及98例亚临床甲状腺功能减退妊娠妇女(SCHO组),所有患者均给予左旋甲状腺素(L-T4)治疗,选择同期甲状腺功能正常的妊娠妇女300例作对照组,对三组进行妊娠结局分析比较。结果 OH组孕妇胎膜早破的发生率(27.2%)高于对照组(17.0%),差异有统计学意义(P<0.05);OH组和SCHO组孕妇早产、妊娠期高血压疾病、羊水过少、妊娠期糖尿病、产后出血、剖宫产率发生率与对照组比较,差异无统计学意义(P>0.05)。结论临床甲状腺功能减退和亚临床甲状腺功能减退孕妇经规范激素(L-T4)替代治疗不良妊娠结局发生情况与正常孕妇相似。
目的:分析妊娠閤併臨床甲狀腺功能減退及亞臨床甲狀腺功能減退經激素替代治療後妊娠結跼。方法迴顧分析2012年1月~2013年12月廣東省深圳市南山區婦幼保健院產科92例臨床甲狀腺功能減退(OH組)及98例亞臨床甲狀腺功能減退妊娠婦女(SCHO組),所有患者均給予左鏇甲狀腺素(L-T4)治療,選擇同期甲狀腺功能正常的妊娠婦女300例作對照組,對三組進行妊娠結跼分析比較。結果 OH組孕婦胎膜早破的髮生率(27.2%)高于對照組(17.0%),差異有統計學意義(P<0.05);OH組和SCHO組孕婦早產、妊娠期高血壓疾病、羊水過少、妊娠期糖尿病、產後齣血、剖宮產率髮生率與對照組比較,差異無統計學意義(P>0.05)。結論臨床甲狀腺功能減退和亞臨床甲狀腺功能減退孕婦經規範激素(L-T4)替代治療不良妊娠結跼髮生情況與正常孕婦相似。
목적:분석임신합병림상갑상선공능감퇴급아림상갑상선공능감퇴경격소체대치료후임신결국。방법회고분석2012년1월~2013년12월광동성심수시남산구부유보건원산과92례림상갑상선공능감퇴(OH조)급98례아림상갑상선공능감퇴임신부녀(SCHO조),소유환자균급여좌선갑상선소(L-T4)치료,선택동기갑상선공능정상적임신부녀300례작대조조,대삼조진행임신결국분석비교。결과 OH조잉부태막조파적발생솔(27.2%)고우대조조(17.0%),차이유통계학의의(P<0.05);OH조화SCHO조잉부조산、임신기고혈압질병、양수과소、임신기당뇨병、산후출혈、부궁산솔발생솔여대조조비교,차이무통계학의의(P>0.05)。결론림상갑상선공능감퇴화아림상갑상선공능감퇴잉부경규범격소(L-T4)체대치료불량임신결국발생정황여정상잉부상사。
Objective To explore the pregnancy outcome on Hormone replacement therapy of clinical hypothyroidism and subclinical hypothyroidism during pregnancy. Methods 92 pregnancy women with clinical hypothyroidism (OH group)and 98 pregnancy women with subclinical hypothyroidism during pregnancy (SCHO group)from January 2012 to December 2013 in Department of Obstetrics of Nanshan District Maternal and Child Health Care of Shenzhen City were retrospectively analyzed, all these patients were given the treatment of sodiumlevothyroxine (L-T4), and 300 nor-mal pregnancy women in the same period were selected as control group. The outcome of pregnancy in three groups were analyzed. Results The incidence of premature rupture of membrane in OH group (27.2%) was higher than that in the control group (17.0%), the difference of two groups was statistically significant (P<0.05). There was no statistically significant difference in the occurrence rate of premature delivery, hypertensive disorder complicating pregnancy, oligo-hydramnios, gestational diabetes mellitus, postpartum hemorrhage, cesarean among the three groups (P>0.05). Conclu-sion The L-T4 replacement therapy of hypothyroidism during pregnancy can improve the adverse outcome of pregnancy.